Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry

A suitable powder formulation for the incorporation of live Newcastle disease vaccines was developed by spray drying. Dry powders containing a live-attenuated Newcastle disease vaccine (LZ58 strain) and intended for mass vaccination of poultry were prepared by spray drying using mannitol in combinat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmaceutics and biopharmaceutics 2012-04, Vol.80 (3), p.649-656
Hauptverfasser: Huyge, Katrien, Van Reeth, Kristien, De Beer, Thomas, Landman, Wil J.M., van Eck, Jo H.H., Remon, Jean Paul, Vervaet, Chris
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 656
container_issue 3
container_start_page 649
container_title European journal of pharmaceutics and biopharmaceutics
container_volume 80
creator Huyge, Katrien
Van Reeth, Kristien
De Beer, Thomas
Landman, Wil J.M.
van Eck, Jo H.H.
Remon, Jean Paul
Vervaet, Chris
description A suitable powder formulation for the incorporation of live Newcastle disease vaccines was developed by spray drying. Dry powders containing a live-attenuated Newcastle disease vaccine (LZ58 strain) and intended for mass vaccination of poultry were prepared by spray drying using mannitol in combination with trehalose or inositol, polyvinylpyrrolidone (PVP) and/or bovine serum albumin (BSA) as stabilizers. These powders were evaluated for vaccine stabilizing capacity during production and storage (at 6°C and 25°C), moisture content, hygroscopicity and dry powder dispersibility. A mixture design, varying the ratio of mannitol, inositol and BSA, was used to select the stabilizer combination which resulted in the desired powder properties (i.e. good vaccine stability during production and storage, low moisture content and hygroscopicity and good dry dispersibility). Inositol-containing powders had the same vaccine stabilizing capacity as trehalose powders, but were less hygroscopic. Incorporation of BSA enhanced the vaccine stability in the powders compared to PVP-containing formulations. However, increasing the BSA concentration increased the hygroscopicity and reduced the dry dispersibility of the powder. No valid mathematical model could be calculated for vaccine stability during production or storage, but the individual experiments indicated that a formulation combining mannitol, inositol and BSA in a ratio of 73.3:13.3:13.3 (wt/wt) resulted in the lowest vaccine titre loss during production (1.6–2.0 log10 50% egg infectious dose (EID50) and storage at 6°C (max. 0.8 log10 EID50 after 6months) in combination with a low moisture content (1.1–1.4%), low hygroscopicity (1.9–2.1% water uptake at 60% relative humidity) and good dry dispersibility properties.
doi_str_mv 10.1016/j.ejpb.2011.11.018
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_927831207</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0939641111003365</els_id><sourcerecordid>927831207</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-ba9f3643c486d7c8c509142184e0f782099cb5a63dbc2ac525eac89752f066993</originalsourceid><addsrcrecordid>eNp9kUtrFUEQhRsxmJvoH3AhsxHdzLUf0y9wE4LGQEgW6rrp6amGvs7L7p6E-ff2cK-6CxQUFN85VdRB6C3Be4KJ-HTYw2Fu9xQTsi-FiXqBdkRJVrOmIS_RDmuma9EQco4uUjpgjBvJ1St0TinhXAq2Q7--LyHbNvQhr9Xkqy54DxHG3K-Vn-Kw9DZDV3VxrebpqYNY3cOTsyn3UNgENkH1aJ0LI6RNUA02pdPE5jCNm-k8LX2O62t05m2f4M2pX6KfX7_8uP5W3z3c3F5f3dWuETTXrdWeiYa5RolOOuU41qShRDWAvVQUa-1abgXrWket45SDdUpLTj0WQmt2iT4cfec4_V4gZTOE5KDv7QjTkoymUjFCsSzkx2dJophkWDDMCkqPqItTShG8mWMYbFwNwWaLwxzMFofZ4jClShxF9O7kv7QDdP8kf_9fgPcnwCZnex_t6EL6z3FZVmNcuM9HDsrfHgNEk1yA0UEXIrhsuik8d8cfwvOpWw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1837306303</pqid></control><display><type>article</type><title>Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Huyge, Katrien ; Van Reeth, Kristien ; De Beer, Thomas ; Landman, Wil J.M. ; van Eck, Jo H.H. ; Remon, Jean Paul ; Vervaet, Chris</creator><creatorcontrib>Huyge, Katrien ; Van Reeth, Kristien ; De Beer, Thomas ; Landman, Wil J.M. ; van Eck, Jo H.H. ; Remon, Jean Paul ; Vervaet, Chris</creatorcontrib><description>A suitable powder formulation for the incorporation of live Newcastle disease vaccines was developed by spray drying. Dry powders containing a live-attenuated Newcastle disease vaccine (LZ58 strain) and intended for mass vaccination of poultry were prepared by spray drying using mannitol in combination with trehalose or inositol, polyvinylpyrrolidone (PVP) and/or bovine serum albumin (BSA) as stabilizers. These powders were evaluated for vaccine stabilizing capacity during production and storage (at 6°C and 25°C), moisture content, hygroscopicity and dry powder dispersibility. A mixture design, varying the ratio of mannitol, inositol and BSA, was used to select the stabilizer combination which resulted in the desired powder properties (i.e. good vaccine stability during production and storage, low moisture content and hygroscopicity and good dry dispersibility). Inositol-containing powders had the same vaccine stabilizing capacity as trehalose powders, but were less hygroscopic. Incorporation of BSA enhanced the vaccine stability in the powders compared to PVP-containing formulations. However, increasing the BSA concentration increased the hygroscopicity and reduced the dry dispersibility of the powder. No valid mathematical model could be calculated for vaccine stability during production or storage, but the individual experiments indicated that a formulation combining mannitol, inositol and BSA in a ratio of 73.3:13.3:13.3 (wt/wt) resulted in the lowest vaccine titre loss during production (1.6–2.0 log10 50% egg infectious dose (EID50) and storage at 6°C (max. 0.8 log10 EID50 after 6months) in combination with a low moisture content (1.1–1.4%), low hygroscopicity (1.9–2.1% water uptake at 60% relative humidity) and good dry dispersibility properties.</description><identifier>ISSN: 0939-6411</identifier><identifier>EISSN: 1873-3441</identifier><identifier>DOI: 10.1016/j.ejpb.2011.11.018</identifier><identifier>PMID: 22155763</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Administration, Inhalation ; Animals ; Biological and medical sciences ; Cattle ; Chemistry, Pharmaceutical - methods ; Desiccation - methods ; Drug Design ; Drug Stability ; Drug Storage ; Dry Powder Inhalers - methods ; Dry powder vaccine ; Excipients - chemistry ; General pharmacology ; Humidity ; Inositol - chemistry ; Live-attenuated vaccine ; Mannitol ; Mannitol - chemistry ; Mass poultry vaccination ; Mass Vaccination - methods ; Medical sciences ; Newcastle disease ; Newcastle Disease - immunology ; Newcastle Disease - prevention &amp; control ; Newcastle disease virus - chemistry ; Newcastle disease virus - immunology ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Poultry ; Povidone - chemistry ; Powders - chemistry ; Serum Albumin, Bovine ; Spray drying ; Trehalose - chemistry ; Viral Vaccines - chemistry ; Viral Vaccines - immunology ; Wettability</subject><ispartof>European journal of pharmaceutics and biopharmaceutics, 2012-04, Vol.80 (3), p.649-656</ispartof><rights>2011 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-ba9f3643c486d7c8c509142184e0f782099cb5a63dbc2ac525eac89752f066993</citedby><cites>FETCH-LOGICAL-c462t-ba9f3643c486d7c8c509142184e0f782099cb5a63dbc2ac525eac89752f066993</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejpb.2011.11.018$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25703300$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22155763$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huyge, Katrien</creatorcontrib><creatorcontrib>Van Reeth, Kristien</creatorcontrib><creatorcontrib>De Beer, Thomas</creatorcontrib><creatorcontrib>Landman, Wil J.M.</creatorcontrib><creatorcontrib>van Eck, Jo H.H.</creatorcontrib><creatorcontrib>Remon, Jean Paul</creatorcontrib><creatorcontrib>Vervaet, Chris</creatorcontrib><title>Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry</title><title>European journal of pharmaceutics and biopharmaceutics</title><addtitle>Eur J Pharm Biopharm</addtitle><description>A suitable powder formulation for the incorporation of live Newcastle disease vaccines was developed by spray drying. Dry powders containing a live-attenuated Newcastle disease vaccine (LZ58 strain) and intended for mass vaccination of poultry were prepared by spray drying using mannitol in combination with trehalose or inositol, polyvinylpyrrolidone (PVP) and/or bovine serum albumin (BSA) as stabilizers. These powders were evaluated for vaccine stabilizing capacity during production and storage (at 6°C and 25°C), moisture content, hygroscopicity and dry powder dispersibility. A mixture design, varying the ratio of mannitol, inositol and BSA, was used to select the stabilizer combination which resulted in the desired powder properties (i.e. good vaccine stability during production and storage, low moisture content and hygroscopicity and good dry dispersibility). Inositol-containing powders had the same vaccine stabilizing capacity as trehalose powders, but were less hygroscopic. Incorporation of BSA enhanced the vaccine stability in the powders compared to PVP-containing formulations. However, increasing the BSA concentration increased the hygroscopicity and reduced the dry dispersibility of the powder. No valid mathematical model could be calculated for vaccine stability during production or storage, but the individual experiments indicated that a formulation combining mannitol, inositol and BSA in a ratio of 73.3:13.3:13.3 (wt/wt) resulted in the lowest vaccine titre loss during production (1.6–2.0 log10 50% egg infectious dose (EID50) and storage at 6°C (max. 0.8 log10 EID50 after 6months) in combination with a low moisture content (1.1–1.4%), low hygroscopicity (1.9–2.1% water uptake at 60% relative humidity) and good dry dispersibility properties.</description><subject>Administration, Inhalation</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cattle</subject><subject>Chemistry, Pharmaceutical - methods</subject><subject>Desiccation - methods</subject><subject>Drug Design</subject><subject>Drug Stability</subject><subject>Drug Storage</subject><subject>Dry Powder Inhalers - methods</subject><subject>Dry powder vaccine</subject><subject>Excipients - chemistry</subject><subject>General pharmacology</subject><subject>Humidity</subject><subject>Inositol - chemistry</subject><subject>Live-attenuated vaccine</subject><subject>Mannitol</subject><subject>Mannitol - chemistry</subject><subject>Mass poultry vaccination</subject><subject>Mass Vaccination - methods</subject><subject>Medical sciences</subject><subject>Newcastle disease</subject><subject>Newcastle Disease - immunology</subject><subject>Newcastle Disease - prevention &amp; control</subject><subject>Newcastle disease virus - chemistry</subject><subject>Newcastle disease virus - immunology</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Poultry</subject><subject>Povidone - chemistry</subject><subject>Powders - chemistry</subject><subject>Serum Albumin, Bovine</subject><subject>Spray drying</subject><subject>Trehalose - chemistry</subject><subject>Viral Vaccines - chemistry</subject><subject>Viral Vaccines - immunology</subject><subject>Wettability</subject><issn>0939-6411</issn><issn>1873-3441</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUtrFUEQhRsxmJvoH3AhsxHdzLUf0y9wE4LGQEgW6rrp6amGvs7L7p6E-ff2cK-6CxQUFN85VdRB6C3Be4KJ-HTYw2Fu9xQTsi-FiXqBdkRJVrOmIS_RDmuma9EQco4uUjpgjBvJ1St0TinhXAq2Q7--LyHbNvQhr9Xkqy54DxHG3K-Vn-Kw9DZDV3VxrebpqYNY3cOTsyn3UNgENkH1aJ0LI6RNUA02pdPE5jCNm-k8LX2O62t05m2f4M2pX6KfX7_8uP5W3z3c3F5f3dWuETTXrdWeiYa5RolOOuU41qShRDWAvVQUa-1abgXrWket45SDdUpLTj0WQmt2iT4cfec4_V4gZTOE5KDv7QjTkoymUjFCsSzkx2dJophkWDDMCkqPqItTShG8mWMYbFwNwWaLwxzMFofZ4jClShxF9O7kv7QDdP8kf_9fgPcnwCZnex_t6EL6z3FZVmNcuM9HDsrfHgNEk1yA0UEXIrhsuik8d8cfwvOpWw</recordid><startdate>20120401</startdate><enddate>20120401</enddate><creator>Huyge, Katrien</creator><creator>Van Reeth, Kristien</creator><creator>De Beer, Thomas</creator><creator>Landman, Wil J.M.</creator><creator>van Eck, Jo H.H.</creator><creator>Remon, Jean Paul</creator><creator>Vervaet, Chris</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20120401</creationdate><title>Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry</title><author>Huyge, Katrien ; Van Reeth, Kristien ; De Beer, Thomas ; Landman, Wil J.M. ; van Eck, Jo H.H. ; Remon, Jean Paul ; Vervaet, Chris</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-ba9f3643c486d7c8c509142184e0f782099cb5a63dbc2ac525eac89752f066993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Administration, Inhalation</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cattle</topic><topic>Chemistry, Pharmaceutical - methods</topic><topic>Desiccation - methods</topic><topic>Drug Design</topic><topic>Drug Stability</topic><topic>Drug Storage</topic><topic>Dry Powder Inhalers - methods</topic><topic>Dry powder vaccine</topic><topic>Excipients - chemistry</topic><topic>General pharmacology</topic><topic>Humidity</topic><topic>Inositol - chemistry</topic><topic>Live-attenuated vaccine</topic><topic>Mannitol</topic><topic>Mannitol - chemistry</topic><topic>Mass poultry vaccination</topic><topic>Mass Vaccination - methods</topic><topic>Medical sciences</topic><topic>Newcastle disease</topic><topic>Newcastle Disease - immunology</topic><topic>Newcastle Disease - prevention &amp; control</topic><topic>Newcastle disease virus - chemistry</topic><topic>Newcastle disease virus - immunology</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Poultry</topic><topic>Povidone - chemistry</topic><topic>Powders - chemistry</topic><topic>Serum Albumin, Bovine</topic><topic>Spray drying</topic><topic>Trehalose - chemistry</topic><topic>Viral Vaccines - chemistry</topic><topic>Viral Vaccines - immunology</topic><topic>Wettability</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huyge, Katrien</creatorcontrib><creatorcontrib>Van Reeth, Kristien</creatorcontrib><creatorcontrib>De Beer, Thomas</creatorcontrib><creatorcontrib>Landman, Wil J.M.</creatorcontrib><creatorcontrib>van Eck, Jo H.H.</creatorcontrib><creatorcontrib>Remon, Jean Paul</creatorcontrib><creatorcontrib>Vervaet, Chris</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutics and biopharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huyge, Katrien</au><au>Van Reeth, Kristien</au><au>De Beer, Thomas</au><au>Landman, Wil J.M.</au><au>van Eck, Jo H.H.</au><au>Remon, Jean Paul</au><au>Vervaet, Chris</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry</atitle><jtitle>European journal of pharmaceutics and biopharmaceutics</jtitle><addtitle>Eur J Pharm Biopharm</addtitle><date>2012-04-01</date><risdate>2012</risdate><volume>80</volume><issue>3</issue><spage>649</spage><epage>656</epage><pages>649-656</pages><issn>0939-6411</issn><eissn>1873-3441</eissn><abstract>A suitable powder formulation for the incorporation of live Newcastle disease vaccines was developed by spray drying. Dry powders containing a live-attenuated Newcastle disease vaccine (LZ58 strain) and intended for mass vaccination of poultry were prepared by spray drying using mannitol in combination with trehalose or inositol, polyvinylpyrrolidone (PVP) and/or bovine serum albumin (BSA) as stabilizers. These powders were evaluated for vaccine stabilizing capacity during production and storage (at 6°C and 25°C), moisture content, hygroscopicity and dry powder dispersibility. A mixture design, varying the ratio of mannitol, inositol and BSA, was used to select the stabilizer combination which resulted in the desired powder properties (i.e. good vaccine stability during production and storage, low moisture content and hygroscopicity and good dry dispersibility). Inositol-containing powders had the same vaccine stabilizing capacity as trehalose powders, but were less hygroscopic. Incorporation of BSA enhanced the vaccine stability in the powders compared to PVP-containing formulations. However, increasing the BSA concentration increased the hygroscopicity and reduced the dry dispersibility of the powder. No valid mathematical model could be calculated for vaccine stability during production or storage, but the individual experiments indicated that a formulation combining mannitol, inositol and BSA in a ratio of 73.3:13.3:13.3 (wt/wt) resulted in the lowest vaccine titre loss during production (1.6–2.0 log10 50% egg infectious dose (EID50) and storage at 6°C (max. 0.8 log10 EID50 after 6months) in combination with a low moisture content (1.1–1.4%), low hygroscopicity (1.9–2.1% water uptake at 60% relative humidity) and good dry dispersibility properties.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>22155763</pmid><doi>10.1016/j.ejpb.2011.11.018</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0939-6411
ispartof European journal of pharmaceutics and biopharmaceutics, 2012-04, Vol.80 (3), p.649-656
issn 0939-6411
1873-3441
language eng
recordid cdi_proquest_miscellaneous_927831207
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Administration, Inhalation
Animals
Biological and medical sciences
Cattle
Chemistry, Pharmaceutical - methods
Desiccation - methods
Drug Design
Drug Stability
Drug Storage
Dry Powder Inhalers - methods
Dry powder vaccine
Excipients - chemistry
General pharmacology
Humidity
Inositol - chemistry
Live-attenuated vaccine
Mannitol
Mannitol - chemistry
Mass poultry vaccination
Mass Vaccination - methods
Medical sciences
Newcastle disease
Newcastle Disease - immunology
Newcastle Disease - prevention & control
Newcastle disease virus - chemistry
Newcastle disease virus - immunology
Particle Size
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Poultry
Povidone - chemistry
Powders - chemistry
Serum Albumin, Bovine
Spray drying
Trehalose - chemistry
Viral Vaccines - chemistry
Viral Vaccines - immunology
Wettability
title Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A57%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suitability%20of%20differently%20formulated%20dry%20powder%20Newcastle%20disease%20vaccines%20for%20mass%20vaccination%20of%20poultry&rft.jtitle=European%20journal%20of%20pharmaceutics%20and%20biopharmaceutics&rft.au=Huyge,%20Katrien&rft.date=2012-04-01&rft.volume=80&rft.issue=3&rft.spage=649&rft.epage=656&rft.pages=649-656&rft.issn=0939-6411&rft.eissn=1873-3441&rft_id=info:doi/10.1016/j.ejpb.2011.11.018&rft_dat=%3Cproquest_cross%3E927831207%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1837306303&rft_id=info:pmid/22155763&rft_els_id=S0939641111003365&rfr_iscdi=true